The Diagnostic Value of Whole-Exome Sequencing in a Spectrum of Rare Neurological Disorders Associated with Cerebellar Atrophy
Molecular Neurobiology - Trang 1-13 - 2023
Tóm tắt
Several neurological disorders, neurodevelopmental disorders, and neurodegenerative disorders have a genetic element with various clinical presentations ranging from mild to severe presentation. Neurological disorders are rare multifactorial disorders characterized by dysfunction and degeneration of synapses, neurons, and glial cells which are essential for movement, coordination, muscle strength, sensation, and cognition. The cerebellum might be involved at any time, either during development and maturation or later in life. Herein, we describe a spectrum of NDDs and NDs in seven patients from six Egyptian families. The core clinical and radiological features of our patients included dysmorphic features, neurodevelopmental delay or regression, gait abnormalities, skeletal deformities, visual impairment, seizures, and cerebellar atrophy. Previously unreported clinical phenotypic findings were recorded. Whole-exome sequencing (WES) was performed followed by an in silico analysis of the detected genetic variants’ effect on the protein structure. Three novel variants were identified in three genes MFSD8, AGTPBP1, and APTX, and other previously reported three variants have been detected in “TPP1, AGTPBP1, and PCDHGC4” genes. In this cohort, we described the detailed unique phenotypic characteristics given the identified genetic profile in patients with neurological “neurodevelopmental disorders and neurodegenerative disorders” disorders associated with cerebellar atrophy, hence expanding the mutational spectrum of such disorders.
Tài liệu tham khảo
Temtamy S, Aglan M (2012) Consanguinity and genetic disorders in Egypt. Middle East J Med Genet 1:12–17. https://doi.org/10.1097/01.MXE.0000407744.14663.d8
Lee H, Nelson SF (2020) The frontiers of sequencing in undiagnosed neurodevelopmental diseases. Curr Opin Genet Dev 65:76–83. https://doi.org/10.1016/j.gde.2020.05.003
Chérot E, Keren B, Dubourg C et al (2018) Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of 2 clinical units and 216 patients. Clin Genet 93(3):567–576. https://doi.org/10.1111/cge.13102
Mastrangelo M (2019) Clinical approach to neurodegenerative disorders in childhood: an updated overview. Acta Neurol Belg 119(4):511–521. https://doi.org/10.1007/s13760-019-01160-0
Córdoba M, Rodriguez-Quiroga SA, Vega PA et al (2018) Whole exome sequencing in neurogenetic odysseys: an effective, cost- and time-saving diagnostic approach. PLoS ONE 13(2):e0191228. https://doi.org/10.1371/journal.pone.0191228
Johnston M (2016) Neurodegenerative disorders of childhood. In: Behrman RE, Kliegman RM, Jenson HB, Nelson textbook of pediatrics (20th edn.) Elsevier, Philadelphia, ISBN: 978–1–4557–7566–8
Jan MM (2002) Clinical approach to children with suspected neurodegenerative disorders. Neurosciences 7:2–6 (Riyadh)
Blaser SI, Steinlin M, Al-Maawali A et al (2016) The Pediatric Cerebellum in inherited neurodegenerative disorders: a pattern-recognition approach. Neuroimaging Clin N Am 26(3):373–416. https://doi.org/10.1016/j.nic.2016.03.007
Stephenson J, Nutma E, van der Valk P et al (2018) Inflammation in CNS neurodegenerative diseases. Immunology 154:204–219. https://doi.org/10.1111/imm.12922
Tanner JM, Hiernaux J, Jarman S (1969) Growth and physique studies. In: Human Biology, A Guide to Field Methods (Weiner JS, Lourie JA, eds). IBP Handbook No. 9. Oxford: Blackwell, International Biological Programme, pp 2–71
Verma RS, Babu A (1995) Human chromosomes: principles and techniques McGraw-Hill, New York.https://doi.org/10.1002/mrd.1996.1080430105
Jiang H, Lei R, Ding SW et al (2014) Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinforma 15:182. https://doi.org/10.1186/1471-2105-15-182
Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164. https://doi.org/10.1093/nar/gkq603
Sherry ST, Ward MH, Kholodov M et al (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311. https://doi.org/10.1093/nar/29.1.308
Auton A, Abecasis GR, Altshuler DM et al (2015) A global reference for human genetic variation. Nature 526:68–74. https://doi.org/10.1038/nature15393
Karczewski KJ, Francioli LC, Tiao G et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434–443. https://doi.org/10.1038/s41586-020-2308-7
Untergasser A, Cutcutache I, Koressaar T et al (2012) Primer3-New capabilities and interfaces. Nucleic Acids Res 40:e115. https://doi.org/10.1093/nar/gks596
Sen Dunnen JT, Dalgleish R, Maglott DR et al (2016) HGVS recommendations for the description of sequence variants: 2016 Update. Hum Mutat 37(6):564–569. https://doi.org/10.1002/humu.22981
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–423. https://doi.org/10.1038/gim.2015.30
Shawky RM, El-Awady MY, Elsayed SM et al (2011) Consanguineous matings among Egyptian population. Egypt J Med Hum Genet 12(2):157–163. https://doi.org/10.1016/j.ejmhg.2011.07.001
Ren XT, Wang XH, Ding CH et al (2019) Next-generation sequencing analysis reveals novel pathogenic variants in four Chinese siblings with late-infantile neuronal ceroid lipofuscinosis. Front Genet 25(10):370. https://doi.org/10.3389/fgene.2019.00370
Gardner E, Bailey M, Schulz A et al (2019) Mutation update: review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease. Hum Mutat 40(11):1924–1938. https://doi.org/10.1002/humu.23860
Fietz M, AlSayed M, Burke et al (2016) Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): expert recommendations for early detection and laboratory diagnosis. Mol Genet Metab 119(1–2):160–167. https://doi.org/10.1016/j.ymgme.2016.07.011
Mole S, Gardner E, Schulz A et al (2018) Molecular basis of CLN2 disease: a review and classification of TPP1 gene variants reported worldwide. Mol Genet Metab 123(2):S97. https://doi.org/10.1016/j.ymgme.2017.12.255
Nickel M, Jacoby D, Lezius S et al (2016) Natural history of CLN2 disease: quantitative assessment of disease characteristics and rate of progression. Neuropediatrics 47(S 01). https://doi.org/10.1055/s-0036-1583730
Nickel M, Simonati A, Jacoby D et al (2018) Disease characteristics and progression in patients with late-infantile neuronal ceroidlipofuscinosis type 2 (CLN2) disease: an observational cohort study. Lancet Child Adolesc Health 2(8):582–590. https://doi.org/10.1016/S2352-4642(18)30179-2
Kara E, Tucci A, Manzoni C et al (2016) Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain 139(Pt 7):1904–1918. https://doi.org/10.1093/brain/aww111
Stogmann E, El Tawil S, Wagenstaller J et al (2009) A novel mutation in the MFSD8 gene in late infantile neuronal ceroidlipofuscinosis. Neurogenetics 10:73–77. https://doi.org/10.1007/s10048-008-0153-1
Weisschuh N, Mazzola P, Heinrich T et al (2020) First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy—a case report. BMC Med Genet 21:236. https://doi.org/10.1186/s12881-020-01166-z
Butz ES, Chandrachud U, Mole SE et al (1866) (2020) Moving towards a new era of genomics in the neuronal ceroidlipofuscinoses. Biochim Biophys Acta Mol Basis Dis 9:165571. https://doi.org/10.1016/j.bbadis.2019.165571
Rosenberg JB, Chen A, Kaminsky SM et al (2019) Advances in the treatment of neuronal ceroid lipofuscinosis. Expert Opin Orphan Drugs 7(11):473–500. https://doi.org/10.1080/21678707.2019.1684258
Iqbal M, Maroofian R, Çavdarlı B et al (2021) Biallelic variants in PCDHGC4 cause a novel neurodevelopmental syndrome with progressive microcephaly, seizures, and joint anomalies. Genet Med 23:2138–2149. https://doi.org/10.1038/s41436-021-01260-4
Shashi V, Magiera MM, Klein D et al (2018) Loss of tubulin deglutamylase CCP1 causes infantile-onset neurodegeneration. EMBO J 37(23). https://doi.org/10.15252/embj.2018100540.
Sheffer R, Gur M, Brooks R et al (2019) Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy. Eur J Hum Genet 27:1419–1426. https://doi.org/10.1038/s41431-019-0400-y
Baltanás FC, Berciano MT, Santos E et al (2021) The childhood-onset neurodegeneration with cerebellar atrophy (CONDCA) disease caused by AGTPBP1 gene mutations: the Purkinje cell degeneration mouse as an animal model for the study of this human disease. Biomedicines 9(9):1157. https://doi.org/10.3390/biomedicines9091157
Karakaya M, Paketci C, Altmueller J et al (2019) Biallelic variant in AGTPBP1 causes infantile lower motor neuron degeneration and cerebellar atrophy. Am J Med Genet A 179(8):1580–1584. https://doi.org/10.1002/ajmg.a.61198
Aicardi J, Barbosa C, Andermann E et al (1988) Ataxia-ocular motor apraxia: a syndrome mimicking ataxia-telangiectasia. Ann Neurol 24:497–502. https://doi.org/10.1002/ana.410240404
Anheim M, Fleury M, Monga et al (2010) Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 11:1–12. https://doi.org/10.1007/s10048-009-0196-y
Ababneh NA, Ali D, Al-Kurdi B et al (2020) Identification of APTX disease-causing mutation in two unrelated Jordanian families with cerebellar ataxia and sensitivity to DNA damaging agents. PLoS ONE 15(8):e0236808. https://doi.org/10.1371/journal.pone.0236808